Breast angiosarcoma – Life with Disease

Go back

Breast angiosarcoma is a very rare and aggressive form of cancer that develops in the blood or lymph vessels of the breast. This disease can appear without warning in people who have never had cancer before, or it can emerge years after radiation treatment for breast cancer. Because it is so uncommon, many questions remain about the best ways to recognize and treat it.

Understanding Prognosis and Long-Term Outlook

Breast angiosarcoma carries a serious prognosis that requires open and honest discussion between patients and their medical teams. This cancer behaves differently from more common types of breast cancer, and understanding what lies ahead helps patients and families prepare emotionally and practically for the journey.

The outlook for breast angiosarcoma depends on several important factors. The size and location of the tumor play a significant role, as do whether the cancer is primary (appearing without prior breast cancer) or secondary (developing after radiation treatment). How the cancer responds to treatment also shapes the prognosis considerably.[1]

Generally speaking, angiosarcoma tends to have a poorer prognosis compared to more common breast cancers like invasive ductal carcinoma, which is cancer that begins in the milk ducts and spreads to nearby breast tissue. The aggressive nature of angiosarcoma means that cancer cells can grow quickly and invade surrounding tissues, making treatment more challenging. Even with aggressive treatment approaches that combine surgery, radiation therapy, and chemotherapy, the risk of the cancer returning remains notably high.[7]

For people with advanced or metastatic angiosarcoma—meaning the cancer has spread to other parts of the body—survival times vary considerably. Research indicates that overall survival ranges from six to sixteen months in these advanced cases, though individual experiences can differ significantly based on treatment response and other health factors.[11]

The rarity of this cancer also affects prognosis in a practical way. Because so few people are diagnosed with breast angiosarcoma each year, researchers have had limited opportunities to study it thoroughly. This means that medical teams are still working to determine the most effective treatments to prevent the cancer from spreading or returning after initial treatment.[1]

⚠️ Important
Every person’s cancer journey is unique, and statistics represent averages across many patients. Some individuals respond exceptionally well to treatment and live far longer than expected. Working closely with a specialized cancer team and participating in clinical trials when possible may improve outcomes. Open communication with your healthcare providers about your prognosis helps you make informed decisions about your care and plan for the future.

How the Disease Progresses Without Treatment

Understanding how breast angiosarcoma develops and spreads helps explain why early detection and prompt treatment matter so much. Without medical intervention, this cancer follows a predictable but troubling path that can affect both quality and length of life.

Angiosarcoma begins when cells in the inner lining of blood vessels or lymphatic vessels undergo changes that transform them from normal to abnormal. Unlike healthy cells, which grow, divide, and die in an orderly way, these cancerous cells do not follow normal rules. Instead of dying when they should, they continue multiplying and creating more abnormal cells. These cells eventually cluster together to form tumors that grow from the affected blood vessels.[17]

As the tumor expands, it does not respect the boundaries of normal tissue. The cancerous cells have an aggressive tendency to invade surrounding breast tissue, creating a network of diseased cells that can spread rapidly. This infiltrative behavior makes angiosarcoma particularly difficult to control, as the edges of the tumor are not always clearly defined.[2]

The natural progression of untreated angiosarcoma typically involves local growth first. A person might notice a lump or mass in the breast that grows noticeably over weeks or months. Unlike some cancers that grow slowly, angiosarcoma often demonstrates rapid enlargement that can be alarming. The affected area might also show skin changes, such as discoloration that appears reddish, bluish, or purple, resembling a bruise that never fades.[1]

Beyond local growth, angiosarcoma has a high tendency to spread to distant parts of the body through a process called metastasis. Cancer cells can break away from the original tumor and travel through the bloodstream or lymphatic system to establish new tumors in other organs. The lungs are a common site for angiosarcoma to spread, but it can also reach the liver, bones, and other tissues. Research shows that between sixteen and forty-four percent of people with angiosarcoma present with advanced or metastatic disease at the time of diagnosis.[11]

Without treatment, the progression of the disease not only affects survival but also quality of life. As the tumor grows, it can cause pain, swelling, bleeding, and significant changes in breast appearance. If the cancer spreads to other organs, it interferes with how those organs function, leading to symptoms like shortness of breath if the lungs are affected, or pain and fatigue as the disease burden increases throughout the body.

Possible Complications and Unexpected Developments

Living with breast angiosarcoma involves navigating not only the primary disease but also various complications that can arise during the course of illness. These complications may emerge from the cancer itself or from the intensive treatments required to fight it.

One of the most concerning complications is local recurrence, which means the cancer returns in or near the original location after treatment. Angiosarcoma has a particularly high rate of local recurrence compared to other breast cancers. Even when surgery appears to have removed all visible cancer and the surgical margins—the edges of removed tissue—test negative for cancer cells, microscopic disease may remain. These hidden cells can grow back over time, requiring additional rounds of treatment.[7]

Distant metastasis represents another major complication. When angiosarcoma spreads to other organs, it becomes much more difficult to treat effectively. The lungs are frequently affected, which can lead to breathing difficulties, persistent cough, and reduced ability to engage in physical activities. When the cancer reaches the liver, it may cause abdominal pain, jaundice (yellowing of the skin and eyes), or feelings of fullness even after eating small amounts.[17]

The tumor itself can cause complications at the original site. Because angiosarcoma originates in blood vessels, it can lead to bleeding within the breast tissue. Some people experience bleeding through the skin if the tumor breaks through the surface, creating open sores that are difficult to heal and may become infected. Swelling in the breast or arm, known as lymphedema, can develop if the tumor or its treatment affects the lymphatic vessels that normally drain fluid from these areas.[1]

Treatment-related complications also deserve attention. Surgery for angiosarcoma often requires complete removal of the breast (mastectomy) to ensure clear margins around the tumor. This extensive surgery carries risks including infection, bleeding, and complications related to breast reconstruction if performed. Recovery from such major surgery can be lengthy and emotionally challenging.[10]

Radiation therapy, while helpful in treating secondary angiosarcoma, cannot typically be used again if the cancer develops in an area that previously received radiation. This is because tissues have a lifetime maximum dose of radiation they can safely tolerate. Exceeding this limit can cause severe damage to healthy tissues. For people with radiation-induced angiosarcoma, this limitation restricts treatment options considerably.[1]

Chemotherapy brings its own set of potential complications. The drugs used to treat angiosarcoma can cause fatigue, nausea, hair loss, and increased risk of infections as they affect not only cancer cells but also healthy rapidly-dividing cells throughout the body. Some chemotherapy agents can affect the heart or other organs, requiring careful monitoring during treatment.[12]

Psychological complications should not be overlooked. The rarity of angiosarcoma can leave patients feeling isolated, as they may not find many others with the same diagnosis. The aggressive nature of the disease and poor prognosis statistics can trigger anxiety, depression, and existential distress. These emotional complications affect not only the patient but also family members and close friends who share the burden of the illness.

Impact on Daily Life and Living with the Disease

A diagnosis of breast angiosarcoma affects every dimension of a person’s daily existence. The physical demands of the disease and its treatment intersect with emotional challenges, social relationships, work responsibilities, and personal activities in ways that require significant adaptation and support.

Physically, the disease itself and the treatments used to fight it can drastically reduce energy levels. Many people experience profound fatigue that differs from ordinary tiredness. This cancer-related fatigue does not improve with rest and can make even simple tasks like showering, preparing meals, or walking short distances feel exhausting. The fatigue may worsen during chemotherapy or radiation treatment and can persist for months after treatment ends.[7]

Pain is another physical symptom that can intrude on daily activities. While not all breast angiosarcomas cause pain initially, as the disease progresses or as treatments take effect, various types of discomfort may develop. Surgical pain after mastectomy requires weeks to months of healing, and some people experience chronic pain in the chest wall or arm on the affected side. Neuropathic pain—a burning or tingling sensation caused by nerve damage—can result from surgery or certain chemotherapy drugs.[17]

The visible changes to the breast can profoundly affect body image and self-esteem. Whether from the tumor itself, which may cause discoloration and swelling, or from mastectomy, these physical changes can make a person feel disconnected from their own body. Some individuals struggle with how they look in clothing or feel self-conscious in social situations. Decisions about breast reconstruction add another layer of complexity, as people weigh the benefits of restoring their appearance against additional surgical risks and recovery time.

Emotionally, living with breast angiosarcoma often feels like riding a roller coaster. The initial shock of diagnosis, particularly for younger people with primary angiosarcoma who never expected to develop cancer, can trigger intense fear and disbelief. The reality that this is a rare and aggressive cancer with limited treatment options can feel overwhelming. Many patients describe experiencing anticipatory grief—mourning future plans and dreams that now feel uncertain.[16]

The treatment schedule itself disrupts normal routines significantly. Frequent medical appointments for chemotherapy, radiation, imaging studies, and follow-up examinations require considerable time. Many people find it difficult to maintain full-time employment during active treatment. The unpredictability of how they will feel from day to day makes planning ahead challenging, affecting not only work but also social commitments and family activities.

Relationships can experience strain under the weight of serious illness. Partners may struggle with shifting roles, as the healthy spouse takes on more household responsibilities and caregiving duties. Communication about fears, treatment decisions, and end-of-life wishes requires vulnerability that feels uncomfortable but is necessary. Children in the family need age-appropriate information and reassurance, which can be emotionally draining for parents trying to protect them while being honest about the situation.[15]

Social isolation often develops, sometimes by necessity and sometimes by choice. During periods when the immune system is suppressed by chemotherapy, patients must avoid crowds and people who might be carrying infections. Some people choose to withdraw socially because they feel too tired to engage or because they find it difficult to participate in conversations that feel trivial compared to what they are facing. Friends and acquaintances may inadvertently contribute to isolation by not knowing what to say or how to help.

Financial stress adds another layer of difficulty. Even with health insurance, the costs of cancer treatment can be substantial. Co-pays for multiple appointments, prescription medications, and procedures add up quickly. Lost income from reduced work hours or inability to work compounds the financial burden. Some people face difficult decisions about whether to pursue certain treatments based partly on cost considerations.

Finding strategies to cope with these challenges becomes essential. Many people benefit from working with a mental health professional who specializes in helping cancer patients. Support groups, whether in person or online, provide connection with others who truly understand the experience. Occupational therapists can suggest adaptive equipment and strategies to conserve energy while maintaining independence in daily activities. Physical therapy helps manage pain and rebuild strength after surgery.

⚠️ Important
Give yourself permission to adjust expectations and priorities. Activities and commitments that felt important before diagnosis may need to be set aside temporarily or permanently. Focus energy on what matters most—whether that is time with loved ones, treatments that offer hope, or personal goals that bring meaning. Accept help when offered, and be specific about what would be most useful, whether that is meals, transportation to appointments, or simply company during difficult days.

Supporting Family Members Through Clinical Trials

When a loved one has been diagnosed with breast angiosarcoma, family members naturally want to help in meaningful ways. One area where family support can make a real difference is in exploring and participating in clinical trials, which may offer access to promising new treatments not yet widely available.

Clinical trials are research studies that test new approaches to preventing, detecting, or treating disease. For rare cancers like breast angiosarcoma, clinical trials are particularly valuable because they advance scientific understanding and may provide treatment options beyond the standard approaches. However, finding relevant trials and navigating the enrollment process can feel daunting, especially for someone dealing with the physical and emotional burden of cancer treatment.

Family members can begin by helping research available clinical trials for breast angiosarcoma. Several online databases list trials that are currently recruiting participants. The National Institutes of Health maintains a searchable database where you can enter specific cancer types and locations to find studies accepting new patients. Many cancer centers also have clinical trial coordinators who can search for relevant studies and explain eligibility requirements.

Understanding what clinical trials involve helps families have realistic expectations. Phase I trials test the safety of new treatments and determine appropriate doses. These early studies involve the most uncertainty about whether the treatment will help. Phase II trials evaluate whether the treatment is effective against specific cancers in a larger group of people. Phase III trials compare new treatments against current standard therapies to see if they offer improvements. Each phase serves an important purpose, but they differ in their goals and potential benefits to individual participants.

Families can provide crucial support by attending appointments where clinical trials are discussed. Having an extra set of ears helps because medical information can be overwhelming, especially when someone is anxious about their diagnosis. Take notes during these discussions and ask questions about aspects that are unclear. Important questions include: What is the purpose of this trial? What treatments are involved? What are the potential risks and benefits? How often will appointments be required? Will there be additional costs?

Practical assistance with logistics makes trial participation more manageable. Many trials require frequent visits to the research center, which may be located some distance from home. Family members can help arrange transportation, accompany their loved one to appointments, and assist with paperwork and scheduling. Some trials may help cover travel costs, and families should ask about such assistance.

Emotional support throughout the trial process is equally important. The decision to participate in a clinical trial often brings mixed feelings—hope that the new treatment might help, but also fear about unknowns and whether they are making the right choice. Some people worry about being a “guinea pig” or receiving a placebo instead of active treatment. In cancer trials, participants typically receive either the new treatment or the current best standard treatment, not an inactive placebo, but this should be confirmed for each specific trial.

Families should understand that participation in a clinical trial is always voluntary, and patients can withdraw at any time if they choose. This knowledge provides a sense of control in a situation where so much feels uncontrollable. If the trial treatment is causing unacceptable side effects or does not seem to be helping, the patient has the right to stop and pursue other options.

Keeping organized records becomes increasingly important when participating in research. Family members can help maintain a file with all trial-related documents, including the informed consent form that explains the study details, contact information for the research team, schedules of appointments, and notes about any side effects or concerns. This organization helps ensure nothing falls through the cracks and facilitates communication with the research team.

It is also worth understanding that even if a patient does not directly benefit from participation in a clinical trial, their involvement contributes to advancing knowledge that may help future patients with breast angiosarcoma. Many people find meaning in this contribution, feeling that their experience with this rare disease can potentially help others facing the same diagnosis in the future. Families can acknowledge and honor this altruistic aspect of trial participation.

Finally, family members should remember to take care of themselves while supporting their loved one. The stress of dealing with a serious cancer diagnosis affects everyone in the family. Seeking support for yourself through counseling, support groups for caregivers, or simply connecting with friends and other family members helps you maintain the emotional and physical stamina needed for the long haul. Taking care of yourself is not selfish—it is necessary to be able to effectively support the person with cancer.

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Paclitaxel – A chemotherapy drug that is highly sensitive for treating angiosarcoma and is often administered weekly as single-agent therapy for locally advanced or metastatic disease.
  • Doxorubicin – An anthracycline-based chemotherapy agent used in treatment regimens for angiosarcoma.
  • Gemcitabine – A chemotherapy drug often used in combination regimens (such as with docetaxel) for treating angiosarcoma.
  • Pazopanib – A targeted therapy that inhibits vascular signaling and has shown responses in patients with advanced angiosarcoma.
  • Propranolol – A non-selective beta-blocker that has been studied in combination therapy and has received orphan drug status in Europe for soft tissue sarcoma treatment.

Ongoing Clinical Trials on Breast angiosarcoma

  • Study of Trabectedin alone versus Trabectedin with tTF-NGR combination therapy in adults with metastatic or refractory soft tissue sarcoma who failed first-line treatment

    Recruiting

    1 1 1
    Investigated drugs:
    Germany

References

https://www.breastcancer.org/types/breast-angiosarcoma

https://pmc.ncbi.nlm.nih.gov/articles/PMC4115777/

https://www.cancer.org/cancer/types/breast-cancer/about/types-of-breast-cancer/angiosarcoma-of-the-breast.html

https://pmc.ncbi.nlm.nih.gov/articles/PMC10219174/

https://www.medicalnewstoday.com/articles/angiosarcoma-of-the-breast

http://breastlink.com/breast-cancer-101/rare-breast-cancer-types/angiosarcomas

https://www.aurorahealthcare.org/services/cancer/breast-cancer/angiosarcoma

https://pmc.ncbi.nlm.nih.gov/articles/PMC4056516/

https://www.breastcancer.org/types/breast-angiosarcoma

https://www.facs.org/for-medical-professionals/news-publications/journals/case-reviews/issues/v4n2/14-plichta-primary-angiosarcoma-of-breast/

https://pmc.ncbi.nlm.nih.gov/articles/PMC6895451/

https://emedicine.medscape.com/article/276512-treatment

https://www.cancer.org/cancer/types/breast-cancer/about/types-of-breast-cancer/angiosarcoma-of-the-breast.html

https://www.breastcancer.org/types/breast-angiosarcoma

https://www.mdanderson.org/cancerwise/angiosarcoma-survivo.h00-159063978.html

https://www.nationalbreastcancer.org/blog/diagnosed-with-angiosarcoma-at-20-rachels-story/

https://my.clevelandclinic.org/health/diseases/22778-angiosarcoma

https://www.aurorahealthcare.org/services/cancer/breast-cancer/angiosarcoma

https://www.medicalnewstoday.com/articles/angiosarcoma-of-the-breast

http://breastlink.com/breast-cancer-101/rare-breast-cancer-types/angiosarcomas

https://www.advocatehealth.com/health-services/cancer-institute/cancers-we-treat/breast-cancer/angiosarcoma

FAQ

What is the difference between primary and secondary breast angiosarcoma?

Primary breast angiosarcoma occurs in people who have never had breast cancer before and typically affects younger women in their 30s and 40s. The causes are not well understood. Secondary breast angiosarcoma develops in people who were previously treated for breast cancer, usually appearing seven to ten years after radiation therapy. It may also be associated with lymph node removal and chronic swelling in the breast or arm.

What are the warning signs of breast angiosarcoma?

Common symptoms include a lump in the breast that grows rapidly, discolored skin that looks like a rash or bruise (often purple or blue-hued), thickened areas of skin on the breast, swelling in the breast or arm, and skin lesions that may resemble pimples or skin tags. Unlike typical bruises, these discolored areas do not fade over time. If you notice any of these signs, especially if you previously had radiation treatment for breast cancer, contact your doctor immediately.

Can breast angiosarcoma be cured?

Breast angiosarcoma is a very aggressive cancer with a high risk of recurrence even after intensive treatment. While some patients respond well to treatment and remain disease-free, the overall prognosis is generally poorer than for more common types of breast cancer. Treatment typically involves surgery to remove the tumor with clear margins, and in many cases, complete removal of the breast (mastectomy) is necessary. The cancer’s tendency to come back and spread to other organs makes long-term cure challenging, though individual outcomes vary.

How is breast angiosarcoma diagnosed?

Diagnosis typically begins with a physical examination when a patient reports a concerning lump or skin change. Imaging tests such as mammography, ultrasound, or MRI may be ordered, though angiosarcoma can sometimes be mistaken for benign conditions like fibroadenomas on initial imaging. A biopsy is essential for definitive diagnosis—this involves taking a sample of tissue for examination under a microscope. Pathological and immunohistochemical testing confirms the presence of angiosarcoma and helps distinguish it from other types of breast cancer.

If I had radiation therapy for breast cancer, how worried should I be about developing angiosarcoma?

While the risk is higher for people who received radiation therapy compared to those who did not, the absolute risk remains quite low. Research estimates that approximately one in 1,000 people who had radiation for breast cancer will go on to develop angiosarcoma in the breast or chest wall. The risk is important to be aware of so you can watch for warning signs and report any concerning symptoms to your doctor immediately, but it should not cause excessive worry. Most people who receive radiation for breast cancer will never develop angiosarcoma.

🎯 Key takeaways

  • Breast angiosarcoma is exceptionally rare, affecting only one in one million people annually in the United States.
  • Two distinct types exist: primary angiosarcoma in younger women without prior cancer, and secondary angiosarcoma developing years after radiation treatment for breast cancer.
  • This cancer is notably aggressive, with high rates of local recurrence and distant spread even after intensive treatment.
  • Warning signs include rapidly growing lumps, persistent bruise-like discoloration, and skin changes that may be mistaken for minor skin problems.
  • Complete surgical removal with clear margins, often requiring mastectomy, is the primary treatment approach.
  • Chemotherapy drugs like paclitaxel show particular effectiveness against angiosarcoma compared to other treatments.
  • The disease significantly impacts daily life through fatigue, pain, body image concerns, and disruption of normal routines.
  • Clinical trials may offer access to promising new treatments and contribute to advancing knowledge about this rare cancer.

Connected medications: